Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study

被引:188
作者
Knopman, David S. [1 ]
Mosley, Thomas H. [2 ]
Catellier, Diane J. [3 ]
Coker, Laura H. [4 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[2] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA
[3] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA
[4] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA
关键词
Apolipoprotein E; Stroke; Diabetes; Hypertension; Cognition; MIDLIFE BLOOD-PRESSURE; WHITE-MATTER LESIONS; E EPSILON-4 ALLELE; ATHEROSCLEROSIS RISK; MEMORY PERFORMANCE; ALZHEIMERS-DISEASE; DEMENTIA; DECLINE; ASSOCIATION; STROKE;
D O I
10.1016/j.jalz.2009.01.027
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Strokes, vascular risk factors, and apolipoprotein E (APOE) genotype are associated with cognitive decline in the elderly, but definitive evidence that these affect cognition as early as middle age is limited. Objective: We describe the relationships of APOE genotype, stroke, and vascular risk factors with cognitive change over a 14-year follow-up in the Atherosclerosis Risk in Communities (ARIC) Study cohort recruited while in middle age. Methods: Participants included a subset of the ARIC Study Who underwent assessments of cognitive function and vascular risk factors. Four cognitive assessments were performed between 1990-1992 and 2004-2006. Cognitive assessments included the Delayed Word Recall (DWR) Test, the Digit Symbol Substitution (DSS) Test, and the Word Fluency (WF) Test. Vascular risk factors were assessed during the baseline visit in 1990-1992. Incident stroke was recorded over the 14 years of follow-up. Results: There were 1130 participants (mean age, 59 4.3 [SD] years; 62% women; 52% African-American) with longitudinal data. In multivariate, random-effects linear models adjusted for age, education, gender, and race, the risk factors diabetes and APOE epsilon 4 genotype were independently associated with a decline in performance on the DSS test (both P <.005), whereas hypertension and stroke were not. For DWR, stroke and APOE epsilon 4 genotype were independent predictors of decline (both P < .001). For the WF test, metabolic syndrome, hypertension, and stroke were independently associated with decline (all P <.005). No evidence of differential effects of risk factors on cognitive decline by race, gender, or interactions between risk factors was found. Conclusions: The vascular risk factors diabetes and hypertension, a history of stroke itself, and APOE epsilon 4 genotype independently contribute to cognitive decline in late middle age and early elderly years. (C) 2009 The Alzheimer's Association. All rights reserved.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 43 条
  • [1] SCREENING FOR DEPRESSION IN WELL OLDER ADULTS - EVALUATION OF A SHORT-FORM OF THE CES-D
    ANDRESEN, EM
    MALMGREN, JA
    CARTER, WB
    PATRICK, DL
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1994, 10 (02) : 77 - 84
  • [2] [Anonymous], 1981, Wechsler Adult Intelligence Scale-Revised
  • [3] [Anonymous], 2004, Neuropsychological Assessment
  • [4] Association of apolipoprotein E genotypes with lipid levels and coronary risk
    Bennet, Anna M.
    Di Angelantonio, Emanuele
    Ye, Zheng
    Wensley, Frances
    Dahlin, Anette
    Ahlbom, Anders
    Keavney, Bernard
    Collins, Rory
    Wiman, Bjoern
    de Faire, Ulf
    Danesh, John
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (11): : 1300 - 1311
  • [5] Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer's disease
    Bennett, DA
    Wilson, RS
    Schneider, JA
    Evans, DA
    Aggarwal, NT
    Arnold, SE
    Cochran, EJ
    Berry-Kravis, E
    Bienias, JL
    [J]. NEUROLOGY, 2003, 60 (02) : 246 - 252
  • [6] APOE genotype and cognitive decline in a middle-aged cohort
    Blair, CK
    Folsom, AR
    Knopman, DS
    Bray, MS
    Mosley, TH
    Boerwinkle, E
    [J]. NEUROLOGY, 2005, 64 (02) : 268 - 276
  • [7] Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
    Carmelli, D
    Swan, GE
    Reed, T
    Miller, B
    Wolf, PA
    Jarvik, GP
    Schellenberg, GD
    [J]. NEUROLOGY, 1998, 50 (06) : 1580 - 1585
  • [8] Correlates of cognitive function in middle-aged adults
    Cerhan, JR
    Folsom, AR
    Mortimer, JA
    Shahar, E
    Knopman, DS
    McGovern, PG
    Hays, MA
    Crum, LD
    Heiss, G
    [J]. GERONTOLOGY, 1998, 44 (02) : 95 - 105
  • [9] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [10] de Groot JC, 2000, ANN NEUROL, V47, P145